In previous studies, high MBL levels were shown to increase the susceptibility to lepromatous leprosy [6,34], whereas MBL2 haplotypes/genotypes conferring low MBL levels and deficiency in complement activation, conferred resistance against the development of lepromatous and borderline leprosy [33]. The gene discussed is MBL2; the disease is borderline leprosy.